Thermo Fisher Scientific (TMO) EBT (2009 - 2026)

Thermo Fisher Scientific has reported EBT for 18 years, with the latest figure at $1.9 billion in Q2 2026.

• EBT for Q2 2026 came in at $1.9 billion, up 12.58% year-over-year; the trailing twelve-month figure through Jun 2026 was $7.6 billion (up 8.91% YoY), and the FY2025 annual result was $7.3 billion, up 3.85% from the prior year.
• EBT grew to $1.9 billion in Q2 2026, from $1.7 billion in the prior quarter.
• Over five years, EBT peaked at $2.5 billion in Q2 2022 and troughed at $1.4 billion in Q2 2023.
• A 5-year average of $1.8 billion and a median of $1.8 billion in 2023 frame the typical range for EBT.
• The widest annual swing landed in 2023, when EBT tumbled 46.34%; it then increased 23.43% in 2024.
• A 5-year view of EBT shows it stood at $1.8 billion in 2022, then decreased by 2.08% to $1.7 billion in 2023, then grew by 11.55% to $1.9 billion in 2024, then increased by 10.92% to $2.2 billion in 2025, then retreated by 10.64% to $1.9 billion in 2026.
• Per Business Quant data, the three most recent EBT figures were $1.9 billion in Q2 2026, $1.7 billion in Q1 2026, and $2.2 billion in Q4 2025.